EP. 1: An Overview of PH and PAH
Watch
EP. 2: Considering the Economic Burden of PH and PAH
EP. 3: Identifying Subpopulations of PH and PAH
EP. 4: PH and PAH: An Overview of Treatment Options and Coverage
EP. 5: PH and PAH: Mechanisms of Action of Common Treatment Pathway
EP. 6: Oral, Parenteral, and Inhaled Agents in PH and PAH
EP. 7: Identifying Connective Tissue Disease–Associated PAH
EP. 8: CTD-PAH: Overview of Treatment Strategies
EP. 9: Considering Therapy Based on PH and PAH Subpopulations
EP. 10: Treatment for PH and PAH: Factors That Inform Coverage
EP. 11: CTD-PAH: Adjusting Treatment Based on Patient Factors
EP. 12: Identifying Portopulmonary Hypertension
EP. 13: POPH: Challenges and Treatment Options
EP. 14: Complexity of Chronic Thromboembolic Pulmonary Hypertension
EP. 15: Optimal Management of CTEPH
EP. 16: PH and PAH: Where and From Whom Are Patients Receiving Care
EP. 17: PH and PAH: Care Coordination From the Payer Perspective
EP. 18: PH and PAH: Defining Barriers and Gaps in Care
EP. 19: The Evolving Treatment Landscape of PH and PAH
